V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250000769 | 250006165 | 1.7 | 62 | null | 2019-09-15 | 2019-11-28 | VAI (Ifos 3g/m2) | 02 | N | TRIAL UNSPECIFIED | 101062710 |
| 250000771 | 250006166 | null | null | Palliative (P) | 2020-02-17 | 2020-02-22 | CETUXIMAB | 02 | null | AVELUMAB + AXITINIB | 101609837 |
| 250000823 | 250006170 | 1.74 | 77.7 | null | 2019-11-17 | 2019-12-05 | Rucaparib | 01 | N | PACLITAXEL | 100791807 |
| 250000912 | 250006172 | null | null | null | 2018-04-12 | 2018-05-06 | null | 02 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100191585 |
| 250000919 | 250006173 | null | null | Palliative (P) | 2019-09-22 | 2019-12-31 | NB HRNBL-1 ch14.18/CHO only (trial) | 01 | N | TRABECTEDIN | 101233838 |
| 250001033 | 250006176 | 1.72 | 13.4 | null | 2020-10-08 | 2020-10-24 | Trial Unspecified | 02 | N | CISPLATIN | 100334733 |
| 250001052 | 250006177 | null | null | null | null | 2020-04-14 | CARBOPLATIN + ETOPOSIDE | null | N | GEMCARBO | 101706684 |
| 250001057 | 250006178 | null | null | null | 2018-09-20 | 2018-10-27 | GEMCARBO | 02 | N | FLUOROURACIL + OXALIPLATIN | 101410777 |
| 250001060 | 250006179 | 1.6 | 73.8 | null | 2019-04-02 | 2019-08-26 | null | 02 | null | LIPOSOMAL DOXORUBICIN | 100462361 |
| 250001092 | 250006182 | 1.67 | 56.7 | Neo-adjuvant (N) | null | 2020-01-04 | null | null | N | CAPECITABINE + OXALIPLATIN | 100809939 |
| 250001115 | 250006183 | 1.21 | 94.9 | null | 2020-02-28 | 2020-04-12 | PACLITAXEL | 02 | N | OSIMERTINIB | 101513283 |
| 250001134 | 250006185 | null | null | null | 2018-07-07 | 2018-07-10 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | N | DOXORUBICIN | 100538026 |
| 250001203 | 250006188 | null | null | Palliative (P) | 2014-11-09 | 2014-12-04 | PACLITAXEL | 01 | null | PAZOPANIB | 100629010 |
| 250001291 | 250006191 | null | null | null | 2019-01-06 | 2019-01-06 | Carboplatin AUC 6 - 10 | 02 | null | RIPRETINIB | 100547747 |
| 250001319 | 250006192 | null | null | Palliative (P) | null | 2021-04-21 | Irinotecan + Modified De Gramont | null | null | CARBOPLATIN + PACLITAXEL | 101740740 |
| 250001320 | 250006193 | 1.78 | 0 | Palliative (P) | null | 2018-12-03 | null | 02 | N | CARBOPLATIN + PEMETREXED | 100015616 |
| 250001331 | 250006194 | 1.65 | 75.4 | Curative (C) | 2021-04-08 | 2021-04-17 | Trial Unspecified | 02 | null | CARBOPLATIN + PEMETREXED | 100604720 |
| 250001376 | 250006197 | 1.59 | 14.7 | Curative (C) | 2017-08-27 | 2017-08-27 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | GEMCITABINE | 101349662 |
| 250001418 | 250006198 | null | null | Palliative (P) | null | 2017-07-03 | BCG Intravesical | null | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100062841 |
| 250001458 | 250006199 | 1.85 | 134 | Curative (C) | 2019-08-08 | 2019-08-08 | Pazopanib | 02 | N | TRIAL UNSPECIFIED | 101463193 |
| 250001603 | 250006201 | 1.8 | 56 | Palliative (P) | 2019-11-30 | 2019-11-30 | null | 02 | null | CARBOPLATIN + DOCETAXEL | 100916086 |
| 250001605 | 250006202 | null | null | null | null | 2020-01-23 | Antibody NBL | null | Y | CARBOPLATIN + PACLITAXEL | 101745907 |
| 250001607 | 250006203 | 1.77 | 61.6 | Neo-adjuvant (N) | null | 2020-04-24 | null | 02 | N | IPILIMUMAB + NIVOLUMAB | 100796180 |
| 250001632 | 250006205 | 1.79 | 69.5 | Palliative (P) | 2019-01-13 | 2019-01-21 | null | 02 | N | IMATINIB | 101058742 |
| 250001649 | 250006206 | 1.81 | 72.7 | Palliative (P) | 2020-12-16 | 2020-12-17 | null | 02 | N | CARBOPLATIN + FLUOROURACIL | 101767563 |
| 250001677 | 250006207 | 1.55 | 67 | Neo-adjuvant (N) | 2019-12-05 | 2019-12-26 | null | 02 | N | ATEZOLIZUMAB | 100034115 |
| 250001692 | 250006208 | 1.71 | 84 | Palliative (P) | null | 2019-07-17 | Antibody NBL | 02 | N | NB HRNBL-1 COJEC IND COURSE C | 100928227 |
| 250001697 | 250006209 | 1.63 | 94.6 | null | 2019-09-30 | 2019-11-11 | null | 02 | N | TRIAL UNSPECIFIED | 101840571 |
| 250001751 | 250006210 | 1.74 | 52 | null | 2017-12-15 | 2017-12-15 | CETUXIMAB | 01 | null | TRIAL UNSPECIFIED | 101772420 |
| 250001793 | 250006212 | 1.62 | 46.3 | null | 2018-10-05 | 2018-10-05 | Trial Unspecified | 02 | null | CYCLOPHOSPHAMIDE | 100602541 |
| 250002014 | 250006216 | 0 | 103.7 | null | 2019-03-15 | 2019-04-12 | Carboplatin + Pemetrexed | 02 | N | CISPLATIN | 100115437 |
| 250002203 | 250006218 | 1.83 | 53.4 | null | 2017-08-26 | 2017-12-15 | CISPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + PEMETREXED | 100082985 |
| 250002228 | 250006219 | null | null | Curative (C) | null | 2018-04-23 | Docetaxel | null | N | OLAPARIB | 101712864 |
| 250002240 | 250006220 | 0 | 79 | Palliative (P) | 2019-01-13 | 2019-01-13 | null | 02 | N | CARBOPLATIN + FLUOROURACIL | 100812506 |
| 250002275 | 250006221 | 1.7 | 87.9 | Curative (C) | 2019-06-16 | 2019-06-16 | IPILIMUMAB + NIVOLUMAB | 01 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100548739 |
| 250002352 | 250006223 | 0 | 56 | Palliative (P) | 2018-12-15 | 2019-01-15 | null | 2 | N | IPILIMUMAB + NIVOLUMAB | 100092336 |
| 250002379 | 250006224 | 1.88 | 55.4 | Palliative (P) | null | 2020-06-06 | null | 02 | N | CAPECITABINE + IRINOTECAN | 100537716 |
| 250000328 | 250006226 | 1.7 | 69.2 | null | 2020-01-21 | 2020-03-30 | null | 02 | null | CISPLATIN | 100222763 |
| 250001243 | 250006228 | 1.56 | 60.5 | null | 2018-12-26 | 2018-12-26 | CISPLATIN + FLUOROURACIL | 02 | N | NIRAPARIB | 101824842 |
| 250001761 | 250006231 | null | null | null | null | 2018-05-07 | Cetuximab + CISPLATIN + FLUOROURACIL | null | null | CETUXIMAB | 100399430 |
| 250001986 | 250006232 | 1.66 | 58.4 | null | 2018-08-10 | 2018-08-10 | null | 02 | N | CARBOPLATIN + PEMETREXED | 100407895 |
| 250002073 | 250006233 | 1.75 | 70 | null | null | 2019-09-21 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PEMETREXED | 101020099 |
| 250001038 | 250006552 | 1.58 | 63.6 | null | null | 2017-10-14 | null | null | null | CARBOPLATIN + GEMCITABINE | 101734053 |
| 250001052 | 250006553 | 1.8 | 81.4 | Palliative (P) | 2019-11-21 | 2020-04-15 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101706684 |
| 250001055 | 250006554 | 0 | 77.8 | null | null | 2020-06-05 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100165995 |
| 250001060 | 250006556 | 1.54 | null | null | 2019-12-23 | 2019-12-25 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100462361 |
| 250001062 | 250006557 | 1.69 | 76.5 | null | null | 2019-11-16 | null | null | null | CISPLATIN + GEMCITABINE | 100598391 |
| 250001063 | 250006558 | 1.6 | 88.1 | Palliative (P) | 2020-01-22 | 2020-01-25 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 101811847 |
| 250001065 | 250006559 | 1.77 | 86.6 | null | null | 2019-12-12 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 100698922 |
| 250001066 | 250006560 | 1.63 | 79.4 | null | null | 2019-07-11 | NIVOLUMAB | null | null | NIVOLUMAB | 100280203 |